UPDATE ~ Make Sure You Properly Report AlloDerm During Hernia Repair

Why This Topic Matters

Accurate reporting of biologic graft use during hernia repair can affect claim acceptance and payment methodology. The article helps readers understand which code families are discussed, how payer guidance may differ, and when unlisted-procedure reporting may be considered.

Article Sections

1. AMA guidance on AlloDerm during ventral hernia repair

   Summarizes the coding issue raised for use of AlloDerm in place of mesh during ventral hernia repair and the guidance attributed to the AMA and Medicare.

2. Using an unlisted-procedure code as the comparison basis

   Explains the role of an unlisted-procedure claim in this context and why a listed procedure may be used as a comparison point for payer review.

3. Applicability and limitations across hernia repairs

   Reviews which hernia repair categories are discussed in relation to separate reporting and notes the impact of payer policy and NCCI bundling.